Cadrenal Therapeutics (CVKD) Cash & Equivalents (2022 - 2026)
Cadrenal Therapeutics' Cash & Equivalents was $2.4 million in Q2 2026, down 57.1% from $5.6 million a year earlier but up 4.0% from the prior quarter.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Cadrenal Therapeutics came in at $4.01 million, down 60.0% from FY2024.
- Cash & Equivalents shows a three-year compound annual growth rate of 397.3% (FY2022 to FY2025).
- In earlier years, Cash & Equivalents was $10.02 million in FY2024 (+19.2%), $8.4 million in FY2023 and $32,586 in FY2022.
- Quarterly Cash & Equivalents has moved between $32,586 (Q4 2022) and $10.02 million (Q4 2024) over five years.
- Compared with a year earlier, Cash & Equivalents has declined for four straight quarters, with an average decline of 25.8% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2024 (growth of 56.0%); the worst was Q1 2026 (a decline of 68.5%).
- Per Business Quant data, CVKD's Cash & Equivalents in the three quarters before Q2 2026 was $2.31 million (Q1 2026), $4.01 million (Q4 2025) and $3.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Cadrenal Therapeutics | 2.94 Mn | -9.67 Mn | - | 2.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.40 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 7.34 Mn |
| Dec 31, 2024 | 10.02 Mn |
| Sep 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Mar 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 8.40 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Dec 31, 2022 | 32,586.00 |
API Access
Cadrenal Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CVKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();